- Home
- NRT vs INMB Comparison
NRT vs INMB Comparison
Compare NRT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- INMB
- Stock Information
- Founded
- NRT 1975
- INMB 2015
- Country
- NRT United States
- INMB United States
- Employees
- NRT N/A
- INMB N/A
- Industry
- NRT Oil & Gas Production
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- NRT Energy
- INMB Health Care
- Exchange
- NRT Nasdaq
- INMB Nasdaq
- Market Cap
- NRT 50.9M
- INMB 49.2M
- IPO Year
- NRT N/A
- INMB 2019
- Fundamental
- Price
- NRT $5.63
- INMB $1.73
- Analyst Decision
- NRT
- INMB Hold
- Analyst Count
- NRT 0
- INMB 3
- Target Price
- NRT N/A
- INMB $4.30
- AVG Volume (30 Days)
- NRT 31.0K
- INMB 357.8K
- Earning Date
- NRT 08-29-2025
- INMB 10-30-2025
- Dividend Yield
- NRT 8.53%
- INMB N/A
- EPS Growth
- NRT 24.05
- INMB N/A
- EPS
- NRT 0.59
- INMB N/A
- Revenue
- NRT $6,184,173.00
- INMB $50,000.00
- Revenue This Year
- NRT N/A
- INMB $264.29
- Revenue Next Year
- NRT N/A
- INMB $9,819.61
- P/E Ratio
- NRT $9.60
- INMB N/A
- Revenue Growth
- NRT 18.55
- INMB N/A
- 52 Week Low
- NRT $3.88
- INMB $1.71
- 52 Week High
- NRT $5.87
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- NRT 56.50
- INMB 37.28
- Support Level
- NRT $5.49
- INMB $1.75
- Resistance Level
- NRT $5.71
- INMB $1.89
- Average True Range (ATR)
- NRT 0.18
- INMB 0.10
- MACD
- NRT 0.01
- INMB -0.00
- Stochastic Oscillator
- NRT 80.00
- INMB 0.00
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.